MoU signed for joint Co-Innovation Program with Enterprise Singapore
On November 10, 2023 a significant milestone was reached when Charité - Universitätsmedizin Berlin, Berlin Institute of Health at Charité (BIH) and Enterprise Singapore signed a Memorandum of Understanding (MoU). This forms the basis for the upcoming launch of the Co-Innovation Program. This innovative program facilitates the professional networking of start-ups from Singapore with renowned scientists from Charité and BIH to promote joint research and transfer projects.
The overarching goal of this partnership between BIH and Enterprise Singapore is to create a sustainable innovation program. As part of the program, innovative start-ups from Singapore have the opportunity to apply to Enterprise Singapore in a predefined focus area. Following a quality check by Enterprise Singapore, Charité BIH Innovation (CBI) will take on the task of supporting the start-ups in their search for suitable clinical or research partners at Charité/BIH. This includes projects in the area of clinical validation and certification as well as co-development projects.
After successful matching, companies can apply for funding for their projects at Enterprise Singapore. If the project evaluation is positive, there is the possibility of being reimbursed a part of the project costs (the funding is provided by Enterprise Singapore). After receiving the funding approval, a contract is signed between the start-ups and the partners they have found at Charité/BIH. The entire process up to the signing of the contract is supported by CBI. This exciting collaboration paves the way for innovative research and development projects that will make a significant contribution to medical innovation.